4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-102469
Director sold 688,788 shares at an average $19.09 ($13,149,314)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2026-03-09 | Sale 10b5-1 | −177,690 | $17.72 | $3,148,987 | 5,285,156 | I |
| Kersten Dirk Director | 2026-03-10 | Sale 10b5-1 | −9,482 | $18.21 | $172,687 | 5,275,674 | I |
| Kersten Dirk Director | 2026-03-10 | Sale 10b5-1 | −219,758 | $19.33 | $4,246,823 | 5,055,916 | I |
| Kersten Dirk Director | 2026-03-10 | Sale 10b5-1 | −281,858 | $19.80 | $5,580,817 | 4,774,058 | I |
| Open-market sales · 688,788 sh · avg $19.09 · $13,149,314 | |||||||
Loading xslF345X05/ownership.xml…